← All stocks

MEDICINOVA INC

MNOV Net buying

CIK 0001226616 #4567 in the set updated 21 Sep 2026

Bought (120 mo)

$235.57K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$51.23K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$51.23K

6 of 6 sales

Net

+$184.34K

+$184.34K against sales at will

By person

7 insiders · 42 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kobayashi Yutaka

Director

$140.48K (2)

—

+$140.48K

106,800

0.2170%

$240.30K

+30.6%

IWAKI YUICHI

President and CEO

$62.00K (1)

—

+$62.00K

1,091,933

2.22%

$2.46M

+47.0%

Nagao Hideki

Director

—

$51.23K (6)

−$51.23K

0.0000%

$0.00

—

Ishizaka Yoshio

Director

$25.85K (1)

—

+$25.85K

15,000

0.0305%

$33.75K

+50.0%

Matsuda Kazuko

Chief Medical Officer

$7.24K (1)

—

+$7.24K

322,996

0.6562%

$726.74K

+344.0%

Okajima Masatsune

VP and Head of Japanese Office

—

1,040,530

2.11%

$2.34M

+1,517%

OBrien Geoffrey

Vice President

—

48,318

0.0982%

$108.72K

+866.4%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 93

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 1,613,023

Sales filed before the plan box existed 6

History held since 9 Sep 2016